Company News
Turning Point Brands Pushes ALP Nicotine Pouches Into 11 International Markets
The race to challenge ZYN's grip on the nicotine pouch market just widened. Turning Point Brands — the U.S. company behind Zig-Zag and the FRE pouch brand — is mounting an aggressive international expansion of its ALP nicotine pouch line, with online sales beginning in several European markets in July 2026 and a major new manufacturing deal to back it up. It's a sign of how fast, and how globally, the pouch category is moving.
What's happening
According to reporting from GuruFocus and Seeking Alpha, Turning Point Brands plans to bring ALP to 11 international markets. The first wave of online sales debuts in July 2026 across Britain, Ireland, Greece, Switzerland, and Romania, followed by digital rollouts in the Czech Republic, Poland, Portugal, and Spain in August and September, with Sweden and Denmark — the historic heartland of oral nicotine — slated for later in the year.
To supply that push, ALP has contracted a manufacturing partner in Lithuania, with the facility set to produce 20 million units in 2026 and scale to 50 million in 2027. That's a serious capacity commitment for a brand still building its footprint.
In the U.S., ALP's path runs through the FDA. Along with TPB's FRE brand, ALP is part of the agency's "Fast-Track" pilot program — launched in late 2025 to speed nicotine-pouch reviews — and is currently in the substantive-review phase, meaning it's awaiting a U.S. marketing decision rather than sitting on final authorization.
Why it matters
The pouch category has been defined by ZYN's dominance, but challengers are multiplying — and TPB is positioning ALP and Turning Point Brands Bets Future on FRE Pouches as its twin bets to grab share. A brand that's simultaneously scaling manufacturing and expanding across a dozen markets is signaling it intends to be a serious, lasting competitor, not a niche player.
The honest caveats
- International expansion isn't U.S. availability. The July 2026 launches are European and online; ALP's U.S. status still depends on the FDA review, so a global rollout doesn't guarantee what's on American shelves.
- Fast-track ≠ approved. Being in the FDA's pilot program speeds review but isn't the same as authorization. Until a decision lands, ALP's U.S. future is pending.
- More competition, same risks. A crowded, fast-growing pouch market gives shoppers more choices, but nicotine remains addictive and pouches are not a risk-free product, regardless of brand.
What it means for shoppers and retailers
Expect more pouch brands, not fewer. TPB's push is part of a broader wave of challengers; the ZYN-dominated aisle is diversifying. Retailers should watch the FDA docket, as which pouch brands clear U.S. review will shape what stores can legally stock — ALP and FRE are ones to watch. This shift mirrors how Wall Street Warms Back Up to Tobacco in 2026 through smoke-free formats.
"Turning Point Brands' ALP expansion is a real, dated marker of how competitive and global the nicotine pouch business has become in 2026."
Availability will stay uneven. As with all oral nicotine, what's for sale — and at what price — varies by country and, in the U.S., by state and federal authorization. For those interested in traditional formats, you can still find a wide selection of Tobacco Products & Smoking Accessories online.
The bottom line
For U.S. shoppers, this is more preview than product news — ALP's domestic fate rests with the FDA — but it underscores that the pouch aisle's ZYN era is drawing challengers with real money behind them. As always, these are addictive, adults-only products. For more information on the evolving market, see our Tobacco Guide: Pipe Tobacco, Wraps, Cigarillos & Pouches.